Skip to content
Home/Companies/Biotech/BIONCaRT

BIONCaRT

Biotech·Germany·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns BIONCaRT?

BIONCaRT is a German Biotech company, currently owned by bm-t Beteiligungsmanagement Thueringen since 2024.

Hand-verified · updated 2026-08-16

Open JSON · CC-BY
bm-t Beteiligungsmanagement Thueringen
Investor
bm-t Beteiligungsmanagement Thueringen
Thueringer Startup-Fonds II (TSF II) · 2022 · VC

Key facts

HQGermany
SectorBiotech
StatusActive

More from Thueringer Startup-Fonds II (TSF II)

Other portfolio companies in the same fund.

DeepEn
DeepEn
Active
MedTechGermany· 2025
Leapter
Active
SoftwareGermany· 2025
Perceptec
Active
MedTechGermany· 2025
Zepta Technologies
Zepta Technologies
Active
SoftwareGermany· 2025
Digity
Active
MedTechGermany· 2024
FluIDect
FluIDect
Active
MedTechGermany· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns BIONCaRT?

BIONCaRT is currently owned by bm-t Beteiligungsmanagement Thueringen, through Thueringer Startup-Fonds II (TSF II), since 2024.

When did bm-t Beteiligungsmanagement Thueringen acquire BIONCaRT?

bm-t Beteiligungsmanagement Thueringen acquired BIONCaRT in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue